+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Reperfusion Treatment Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • ID: 5327870
  • Report
  • October 2020
  • Region: Global
  • Coherent Market Insights Pvt Ltd.

FEATURED COMPANIES

  • Amyndas Pharmaceuticals
  • CFM Pharma Holding B.V.
  • Faraday Pharmaceuticals
  • MIFCOR, Inc.
  • Pharming Group NV
  • Revive Therapeutics Ltd.
Reperfusion therapy is used to restore the blood flow in blocked arteries after a heart attack. Reperfusion injury is usually developed due injury to organs during transplantation and others. Patients are treated using anti-platelet therapy, open or endovascular revascularization, coronary angioplasty, and others. Reperfusion injury can occur in organs such as heart, kidney, liver, intestine, lungs, and brain. Currently, clinical trials are being conducted for medicines for the treatment of reperfusion injury.

Market Dynamics

Market players are focusing on various inorganic growth strategies such as mergers and collaborations to strengthen their position in the global market. This is expected to drive the growth of the global reperfusion treatment market during the forecast period. In January 2018, Perfusion.com, Inc. and HEME Perfusion, Inc., providers of outsourced perfusion services, announced their merger. Under this merger agreement, the companies combined their business operations in 2019 and currently operate under the Perfusion.com brand.

Market players are focusing on conducting preclinical trials for a lead product candidate molecule to test the safety and effectiveness of the product in animals. For instance, in 2019, Ischemix conducted preclinical trials for studying the effects of its lead product candidate molecule, CMX-2043, in the treatment of traumatic brain injury. The trials showed positive results by decreasing mitochondrial reactive oxygen species and increasing mitochondrial bioenergetics. Therefore, the lead product reduces the injuries induced by reactive oxygen species in the brain of the animals. Furthermore, the company is planning to carry out phase I trials for the traumatic brain injury in humans.

Key features of the study:
  • This report provides in-depth analysis of the global reperfusion treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global reperfusion treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study are Corline Biomedical AB, SBI Holdings Inc., Pharming Group NV, Mallinckrodt Pharmaceuticals, MIFCOR, Inc., CFM Pharma Holding B.V., Balmes Transplantation SAS, Revive Therapeutics Ltd., Faraday Pharmaceuticals, Radikal Therapeutics Inc., Amyndas Pharmaceuticals, Perfusion.com, Inc., Angion Biomedica Corp., Young Therapeutics, LLC, Ischemix, Stealth Biotherapeutics Inc., and Bolder Bio Technology Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global reperfusion treatment market report caters to various stakeholders in this industry including investors, suppliers, reperfusion therapy manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global reperfusion treatment market.
Detailed Segmentation

Global Reperfusion Treatment Market, By Treatment Type,
  • Therapeutic Hypothermia
  • Cyclosporin
  • Stem Cell Therapy
  • Hydrogen Sulphide Treatment
  • Others
Global Reperfusion Treatment Market, By Injury Type,
  • Heart Injury
  • Kidney Injury
  • Intestine Injury
  • Others
Global Reperfusion Treatment Market, By Distribution Channel,
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Global Reperfusion Treatment Market, By Region,o North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
Company Profiles
  • Corline Biomedical AB*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • SBI Holdings Inc.
  • Pharming Group NV
  • Mallinckrodt Pharmaceuticals
  • MIFCOR, Inc.
  • CFM Pharma Holding B.V.
  • Balmes Transplantation SAS
  • Revive Therapeutics Ltd.
  • Faraday Pharmaceuticals
  • Radikal Therapeutics Inc.
  • Amyndas Pharmaceuticals
  • Perfusion.com, Inc.
  • Angion Biomedica Corp.
  • Young Therapeutics, LLC
  • Ischemix
  • Stealth Biotherapeutics Inc.
  • Bolder Bio Technology Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amyndas Pharmaceuticals
  • CFM Pharma Holding B.V.
  • Faraday Pharmaceuticals
  • MIFCOR, Inc.
  • Pharming Group NV
  • Revive Therapeutics Ltd.
1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations
2. Market Overview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Treatment Type
  • Market Snippet, By Injury Type
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
  • Opportunity Map
3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Regulatory Scenario
  • Epidemiology
  • Key Developments
  • Market Trends
  • Merger and Acquisitions
  • New Product Approvals/Launch
  • Technology Evolution
  • PEST Analysis
  • PORTER’s Analysis
4. Global Reperfusion Treatment Market- Impact of Coronavirus (Covid-19) Pandemic
  • COVID-19 Epidemiology
  • Impact of COVID-19 on Clinical Trials and Drug Development
  • COVID-19 Impact on Overall Drugs Market
5. Global Reperfusion Treatment Market, By Treatment Type, 2016 - 2027 (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Therapeutic Hypothermia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Cyclosporin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Stem Cell Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Hydrogen Sulphide Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
6. Global Reperfusion Treatment Market, By Injury Type, 2016 - 2027 (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2016 - 2027
  • Segment Trends
  • Heart Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Kidney Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Intestine Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
7. Global Reperfusion Treatment Market, By Distribution Channel, 2016 - 2027 (US$ Million)
  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017 - 2027
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
8. Global Reperfusion Treatment Market, By Region, 2016 - 2027 (US$ Million)
  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017 - 2027
  • Regional Trends
  • North America
  • Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Injury Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
  • U.S.
  • Canada
  • Europe
  • Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Injury Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Injury Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
  • Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Injury Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Injury Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Market Size and Forecast, By Treatment Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Injury Type, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Distribution Channel, 2016 - 2027 (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2016 - 2027 (US$ Mn)
  • South Africa
  • Central Africa
  • North Africa
9. Competitive Landscape
  • Heat Map Analysis
  • Company Profiles
  • Corline Biomedical AB
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • SBI Holdings Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Pharming Group NV
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Mallinckrodt Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • MIFCOR, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • CFM Pharma Holding B.V.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Balmes Transplantation SAS
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Revive Therapeutics Ltd.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Faraday Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Radikal Therapeutics Inc
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Amyndas Pharmaceuticals
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Perfusion.com, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Angion Biomedica Corp.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Young Therapeutics, LLC
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Ischemix
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Stealth Biotherapeutics Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Bolder Bio Technology Inc.
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Developments/Updates
  • Strategies
  • Analyst Views
10. Section
  • References
  • Research Methodology
  • About us and Sales Contact
Note: Product cover images may vary from those shown
  • Corline Biomedical AB
  • SBI Holdings Inc.
  • Pharming Group NV
  • Mallinckrodt Pharmaceuticals
  • MIFCOR, Inc.
  • CFM Pharma Holding B.V.
  • Balmes Transplantation SAS
  • Revive Therapeutics Ltd.
  • Faraday Pharmaceuticals
  • Radikal Therapeutics Inc.
  • Amyndas Pharmaceuticals
  • Perfusion.com, Inc.
  • Angion Biomedica Corp.
  • Young Therapeutics, LLC
  • Ischemix
  • Stealth Biotherapeutics Inc.
  • Bolder Bio Technology Inc.
Note: Product cover images may vary from those shown
Adroll
adroll